Inventor
STABLER RUSSELL STEPHEN
US20 patents
⚠️ This page may combine multiple inventors who share the name “STABLER RUSSELL STEPHEN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ROCHE PALO ALTO LLC
12 patentsUS7312359B2Dec 25, 2007
Tetralin and indane derivatives and uses thereof
ROCHE PALO ALTO LLC21 citations92
US7981923B2Jul 19, 2011
Tetralin and indane derivatives and uses thereof
ROCHE PALO ALTO LLC5 citations62
US7531577B2May 12, 2009
Arylsulfonamidyl tetralin derivatives and uses thereof
ROCHE PALO ALTO LLC2 citations62
US7307089B2Dec 11, 2007
Aryloxy quinolines and uses thereof
ROCHE PALO ALTO LLC2 citations62
US7229984B2Jun 12, 2007
Dibenzoxazepinone derivatives and uses thereof
ROCHE PALO ALTO LLC6 citations62
US6943169B2Sep 13, 2005
Quinolinone derivatives and uses thereof
ROCHE PALO ALTO LLC3 citations62
US7473690B2Jan 6, 2009
Tetralin and indane derivatives and uses thereof
ROCHE PALO ALTO LLC2 citations61
US7361648B2Apr 22, 2008
Heterocyclylakylamines as muscarinic receptor antagonists
ROCHE PALO ALTO LLC3 citations61
US9670151B2Jun 6, 2017
Tetralin and indane derivatives and uses thereof
ROCHE PALO ALTO LLC0 citations51
US7671235B2Mar 2, 2010
Tetralin and indane derivatives and uses thereof
ROCHE PALO ALTO LLC0 citations51
US7476675B2Jan 13, 2009
Quinolinone derivatives and uses thereof
ROCHE PALO ALTO LLC0 citations51
US7576103B2Aug 18, 2009
Tetralin and indane derivatives and uses thereof
ROCHE PALO ALTO LLC0 citations40
SYNTEX LLC
5 patentsUS6500822B2Dec 31, 2002
Benzocycloalkylenylamine derivatives as muscarinic receptor antagonists
SYNTEX LLC7 citations73
US6667301B2Dec 23, 2003
Heterocyclylalkylamines as muscarinic receptor antagonists
SYNTEX LLC5 citations72
US6645958B2Nov 11, 2003
Benzocycloalkylenylamine derivatives as muscarinic receptor antagonists
SYNTEX LLC4 citations62
US7094778B2Aug 22, 2006
Heterocyclylalkylamines as muscarinic receptor antagonists
SYNTEX LLC3 citations61
US6818645B2Nov 16, 2004
Benzocycloalkylenylamine derivatives as muscarinic receptor antagonists
SYNTEX LLC0 citations51